Clinical trial
A Phase 1 Study to Assess the Safety, Tolerability, and Immunogenicity of VN-0200 After Intramuscular Injections in Japanese Healthy Adults and Elderly Subjects
NCT04914520 is registered in ClinicalTrials.gov with Daiichi Sankyo Co., Ltd. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase 1 Study to Assess the Safety, Tolerability, and Immunogenicity of VN-0200 After Intramuscular Injections in Japanese Healthy Adults and Elderly Subjects
- Lead sponsor
- Daiichi Sankyo Co., Ltd.
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- June 11, 2021
- Completion date
- December 16, 2021
- Enrollment
- 48 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.